Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Trichoscopy is a quick, cost-effective tool for diagnosing different hair loss conditions.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.

A gene mutation causes lanceolate hair in rats by disrupting hair shaft integrity.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Higher IGF-1 levels in hair follicles link to better finasteride results for hair loss.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

A scale was made to measure hair loss severity in African American women.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Minoxidil response testing helps treat hair loss effectively and safely.

Alefacept does not effectively treat severe alopecia areata.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The article explains how to diagnose and manage certain types of scarring hair loss.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.